Atlas Trials

Neoadjuvant Trastuzumab and Letrozole for Postmenopausal Women

Clinical trial NCT02214004 · UNKNOWN

Trial details

NCT number
NCT02214004
Sponsor
Gangnam Severance Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2015-03-01
Primary completion
2019-03-01
Enrollment
132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.